STELLAR-303
14 Sep 2023
STELLAR-303
NCT05425940
Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer
Exelixis
Cancer Type | Colorectal Cancer |
---|---|
Trial Type | Treatment |
Phase | Phase III |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | - |
Anticipated Start Date | 2023-09-07 |
Anticipated End Date | 2026-02-01 |
Hospital | The Queen Elizabeth Hospital |
---|---|
Clinical Trial Coordinator | Pamela Cooper |
Pamela.cooper@sa.gov.au | |
Phone | 08 8222 6140 |
Principal Investigator | Tim Price |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs